SMTL ID : 3i0f.1

Crystal structure of GTB C80S/C196S + UDP + H antigen

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.56 Å

Oligo State

homo-dimer

Ligands

2 x BHG- FUC: alpha-L-fucopyranose-(1-2)-hexyl beta-D-galactopyranoside(Non-covalent)

BHG-FUC.1: 12 residues within 4Å: Chain A: H.165, P.166, S.167, F.168, T.177, Y.196, M.198, W.232, E.235, D.258, L.261 Ligands: UDP.3 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.261, A:P.166 Hydrogen bonds: A:S.167, A:T.177, A:E.235, A:D.258, A:D.258, A:K.278 Salt bridges: A:H.165 Water bridges: A:K.278 BHG-FUC.5: 12 residues within 4Å: Chain B: H.165, P.166, S.167, F.168, T.177, Y.196, M.198, W.232, E.235, D.258, L.261 Ligands: UDP.7 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:L.261, B:P.166 Hydrogen bonds: B:S.167, B:T.177, B:T.177, B:E.235, B:D.258, B:K.278 Salt bridges: B:H.165 Water bridges: B:K.278

2 x U5P: URIDINE-5'-MONOPHOSPHATE(Non-covalent)

U5P.2: 8 residues within 4Å: Chain A: P.4, S.12, G.30, T.31, F.32, N.33 Chain B: L.17, P.21 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.30, A:T.31 Water bridges: A:E.29, A:T.31, A:I.34 U5P.6: 8 residues within 4Å: Chain A: L.17, P.21 Chain B: P.4, S.12, G.30, T.31, F.32, N.33 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:G.30, B:T.31 Water bridges: B:E.29, B:T.31, B:I.34

2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)

UDP.3: 12 residues within 4Å: Chain A: F.53, A.54, I.55, Y.58, R.120, D.143, V.144, D.145, K.278 Ligands: BHG-FUC.1, BHG-FUC.1, MN.4 13 PLIP interactions: 13 interactions with chain A Hydrogen bonds: A:F.53, A:F.53, A:I.55, A:I.55, A:Y.58, A:V.144, A:D.145 Water bridges: A:R.120, A:K.278, A:K.278 Salt bridges: A:K.278, A:K.278 pi-Stacking: A:Y.58 UDP.7: 12 residues within 4Å: Chain B: F.53, A.54, I.55, Y.58, R.120, D.143, V.144, D.145, K.278 Ligands: BHG-FUC.5, BHG-FUC.5, MN.8 12 PLIP interactions: 12 interactions with chain B Hydrogen bonds: B:F.53, B:F.53, B:I.55, B:I.55, B:V.144, B:D.145 Water bridges: B:R.120, B:K.278, B:K.278 Salt bridges: B:K.278, B:K.278 pi-Stacking: B:Y.58

2 x MN: MANGANESE (II) ION(Non-covalent)

MN.4: 3 residues within 4Å: Chain A: D.143, D.145 Ligands: UDP.3 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.143, A:D.145, A:D.145, H2O.10 MN.8: 3 residues within 4Å: Chain B: D.143, D.145 Ligands: UDP.7 4 PLIP interactions: 3 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.143, B:D.145, B:D.145, H2O.22

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schuman, B. et al., Cysteine-to-serine mutants dramatically reorder the active site of human ABO(H) blood group B glycosyltransferase without affecting activity: structural insights into cooperative substrate binding. J.Mol.Biol. (2010)

Release Date

2010-08-11

Peptides

ABO glycosyltransferase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

ABO glycosyltransferase

Related Entries With Identical Sequence